An anonymous director reports

CURALEAF ANNOUNCES PROPOSED OFFERING OF SUBORDINATE VOTING SHARES

Curaleaf Holdings Inc. is commencing a marketed offering of subordinate voting shares of the company.

The offered securities will be offered in each of the provinces of Canada, other than Quebec, pursuant to a prospectus supplement to the company's base shelf prospectus dated Dec. 30, 2022, and in the United States on a private placement basis to qualified institutional buyers pursuant to exemptions from the registration requirements of the U.S. Securities Act of 1933, as amended, and applicable state securities laws. The prospectus supplement is expected to be filed on Sept. 28, 2023.

The offering is expected to be priced in the context of the market, with the final terms of the offering to be determined at the time of pricing. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The closing of the offering will be subject to market and other customary conditions, including requirements of the Canadian Securities Exchange.

Canaccord Genuity Corp. is acting as the sole underwriter and bookrunner for the offering.

The company is making the offering: (i) to satisfy a condition required for a potential listing of the subordinate voting shares on the Toronto Stock Exchange and plans to use a portion of the proceeds of the offering to finance working capital requirements of its international business operated by Curaleaf Holdings International; and (ii) for general corporate purposes of the company.

Copies of the prospectus, following filing thereof, may be obtained on SEDAR+ under the company's profile and from Canaccord Genuity, 40 Temperance St., Suite 2100, Toronto, Ont., M5H 0B4. The prospectus will contain important detailed information about the company and the proposed offering. Prospective investors should read the prospectus and the other documents the company has filed under its issuer profile on SEDAR+ before making an investment decision.

About Curaleaf Holdings Inc.

Curaleaf is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf, Select and Grassroots, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 19 states with 152 dispensaries, and employs nearly 5,500 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.

We seek Safe Harbor.